BackPyxis Oncology Overview

Pyxis Oncology Long Term Debt

Track Pyxis Oncology's long-term debt ($16M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$16.01M
10.54% YoYΔ $-1.89M vs prior year quarter

Peer trimmed avg / median

Loading

Pyxis Oncology Long Term Debt History

Loading

Pyxis Oncology vs. peers: Long Term Debt Comparison

Loading

Pyxis Oncology Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pyxis Oncology (PYXS) FAQ

As of the most recent data (June 2026), PYXS shows a long-term debt of $16M. That compares with $18M in the prior-year period — down 10.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PYXS's long-term debt is now $16M (was $18M) — a 10.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pyxis Oncology is outperforming or lagging.

Tracking PYXS's long-term debt over time shows whether Pyxis Oncology is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $18M in the prior-year period — down 10.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Pyxis Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $16M) with ownership activity and broader fundamentals.

Pyxis Oncology's long-term debt is $16M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.